CLOSE X
GO

LIC MF Healthcare Fund-Reg(G)

very highequitypharma & health care
29.91 -0.48(-1.59%) NAV as on 20 Dec 2024
3.1 % 1 M
46.79 % 1 Y
18.71 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.44

As on 30 Nov, 2024
age-icon Age :

5 yrs 9 m

Since 28 02 ,2019
exit_load Exit Load :

0%

aum AUM :

84.15 Crs

lock_in Lock-in :

Nil upto 12% of units and 1% for remaining units on or before 90D, Nil after 90D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.62

Min_Investment Min. Investment :

SIP 200 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Karan Doshi

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2024
Others 4.18 %
Equity 95.82 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.87 %
Piramal Pharma Ltd.7.26 %
Artemis Medicare Services Ltd.6.66 %
Torrent Pharmaceuticals Ltd.5.35 %
Syngene International Ltd.4.54 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.52
Hospital & Healthcare Services16.71
Business Support4.54
Chemicals3.04
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)10.0816.2017.9915.8323.71
Net Assets(Rs Crores) (as on 31-Mar-2024) 26.75 64.43 68.30 49.62 61.69
Scheme Returns(%)(Absolute)0.0063.1410.37-12.0149.49
B'mark Returns(%)(Absolute)NANANANANA
Category Rank5/7556/7552/7572/7630/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

LIC MF Healthcare Fund-Reg(G)Very HighEquity29.91-0.48(-1.59%)NAV As on 20 Dec, 202428-Feb-2019Inception Date84.15AUM In Cr.46.79%1Y18.71%3Y23.21%5Y20.74%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.82-0.22(-0.56%)NAV As on 20 Dec, 202413-Jul-2018Inception Date5,044.63AUM In Cr.49.14%1Y25.86%3Y30.25%5Y23.43%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity425.34-3.87(-0.90%)NAV As on 20 Dec, 202414-Jul-1999Inception Date3,459.68AUM In Cr.44.04%1Y25.17%3Y29.24%5Y16.62%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.82-0.25(-0.81%)NAV As on 20 Dec, 202428-Dec-2015Inception Date1,213.92AUM In Cr.42.34%1Y22.74%3Y27.36%5Y13.34%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors